List of Excipients in API alclometasone dipropionate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing alclometasone dipropionate
Detailed excipient profiles for alclometasone dipropionate
Excipient focus: CETETH-20
alclometasone dipropionate drug variants containing CETETH-20
alclometasone dipropionate drug variants not containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
alclometasone dipropionate drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0263 |
| Physicians Total Care Inc | alclometasone dipropionate | 54868-2861 |
| Glenmark Pharmaceuticals Inc USA | alclometasone dipropionate | 68462-300 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1306 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
alclometasone dipropionate drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1306 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing CETYL ALCOHOL
Excipient focus: CHLOROCRESOL
alclometasone dipropionate drug variants containing CHLOROCRESOL
alclometasone dipropionate drug variants not containing CHLOROCRESOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
alclometasone dipropionate drug variants containing GLYCERYL MONOSTEARATE
alclometasone dipropionate drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: HEXYLENE GLYCOL
alclometasone dipropionate drug variants containing HEXYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing HEXYLENE GLYCOL
Excipient focus: PEG-100 STEARATE
alclometasone dipropionate drug variants containing PEG-100 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1306 |
| Physicians Total Care Inc | alclometasone dipropionate | 54868-2861 |
| Glenmark Pharmaceuticals Inc USA | alclometasone dipropionate | 68462-300 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing PEG-100 STEARATE
Excipient focus: PETROLATUM
alclometasone dipropionate drug variants containing PETROLATUM
alclometasone dipropionate drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHOSPHORIC ACID
alclometasone dipropionate drug variants containing PHOSPHORIC ACID
alclometasone dipropionate drug variants not containing PHOSPHORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4500
alclometasone dipropionate drug variants containing POLYETHYLENE GLYCOL 4500
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0263 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing POLYETHYLENE GLYCOL 4500
Excipient focus: PROPYLENE GLYCOL
alclometasone dipropionate drug variants containing PROPYLENE GLYCOL
alclometasone dipropionate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL MONOPALMITOSTEARATE
alclometasone dipropionate drug variants containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
Excipient focus: PROPYLENE GLYCOL MONOSTEARATE
alclometasone dipropionate drug variants containing PROPYLENE GLYCOL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing PROPYLENE GLYCOL MONOSTEARATE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
alclometasone dipropionate drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0263 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1306 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
alclometasone dipropionate drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | alclometasone dipropionate | 54868-2861 |
| Glenmark Pharmaceuticals Inc USA | alclometasone dipropionate | 68462-300 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: STEARYL ALCOHOL
alclometasone dipropionate drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1306 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
alclometasone dipropionate drug variants containing WATER
alclometasone dipropionate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
alclometasone dipropionate drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | alclometasone dipropionate | 0168-0264 |
| Taro Pharmaceuticals USA Inc | alclometasone dipropionate | 51672-1316 |
| >Company | >Ingredient | >NDC |
alclometasone dipropionate drug variants not containing WHITE WAX
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
